Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
02/2011
02/24/2011US20110046139 Benzocycloheptane and benzoxepine derivatives
02/24/2011US20110046128 Novel compounds advantageous in the treatment of central nervous system diseases and disorders
02/24/2011US20110046107 Sulfonyl-substituted carbapenem compounds
02/24/2011US20110045516 Kits Pertaining to Analyte Determination
02/24/2011US20110045359 Reactive ionic liquids
02/24/2011US20110044898 Translocator protein ligands
02/24/2011US20110041261 Azomethine direct dyes or reduced precursors of these dyes obtained from 2-chloro-3-amino-6-methylphenol, and hair dyeing method starting from these dyes and precursors
02/23/2011EP2287153A1 Synthesis Of Renin Inhibitors Involving A Cycloaddition Reaction
02/23/2011EP2285775A1 Therapeutic lactams
02/23/2011EP2035401B1 Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics
02/23/2011EP1227805B2 Mediators of hedgehog signaling pathways, compositions and uses related thereto
02/23/2011CN1942466B Caspase inhibitors and uses thereof
02/23/2011CN101981005A Atorvastatin-aliskiren
02/23/2011CN101981004A Novel crystalline forms
02/23/2011CN101979394A A method to inhibit ethylene responses in plants
02/23/2011CN101979378A Method for synthesizing chiral gamma-lactam compounds
02/23/2011CN101693200B Method for synthesizing glimepiride key intermediate
02/22/2011USRE42164 Hepatitis C inhibitor tri-peptides
02/22/2011US7894695 Tricyclic spacer systems for nonlinear optical devices
02/22/2011US7893280 2,4-disubstituted thiazolyl derivatives
02/22/2011US7893103 Dipeptidyl peptidase IV (DPP-IV); industrial scale process of making antidiabetics such as (2S,4S)-1-{2-[(3SR,1RS)-3-(1H-1,2,4-Triazol-1-ylmethyl)cyclopentylamino]acetyl}-4-fluoro-pyrrolidine-2-carbonitrile starting from ethyl glyoxalate and 3-(1H-1,2,4-triazol-1-ylmethyl)cyclopententylamine for example
02/22/2011US7893098 Pyrrole and pyrazole DAAO inhibitors
02/22/2011US7893062 Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
02/22/2011US7892748 Reagent for detecting an analyte
02/22/2011CA2476296C Amino-derivatives as inhibitors of histone deacetylase
02/17/2011US20110040104 Organocatalyst
02/17/2011US20110040103 Preparation of pentafluorosulfanyl (sf5) heterocycles: pyrroles and thiophenes
02/17/2011US20110040099 Method for manufacturing ruthenium carbene complexes
02/17/2011US20110040090 Process for the preparation of 5-(2-amino-pyrimidin-4-yl)-2-aryl-1h-pyrrole-3-carboxamides
02/17/2011US20110039908 Inhibiting Amyloid-Beta Peptide/Rage Interaction At The Blood-Brain Barrier
02/17/2011US20110039853 N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
02/17/2011US20110039841 Novel compounds, their preparation and use
02/17/2011US20110039819 Substituted phenoxybenzamides
02/17/2011US20110039802 Npy y5 antagonist
02/17/2011US20110039209 Compound and photoresist composition containing the same
02/17/2011US20110038794 Method of radiolabelling carbon nanotubes, radiolabelled carbon nanotubes and applications thereof
02/17/2011CA2808582A1 Imidamide sphingosine kinase inhibitors
02/16/2011EP2284166A1 Arylsulfonamides with analgetic activity
02/16/2011EP2284154A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process
02/16/2011EP2284152A2 Substituted tetracycline compounds
02/16/2011EP2284151A2 Substituted tetracycline compounds
02/16/2011EP2283008A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
02/16/2011EP2283007A2 Pyrrole derivatives, preparation of same and therapeutic application thereof
02/16/2011EP2282992A1 Processes useful for the synthesis of (r)-1-{2-ý4'-(3-methoxypropane-1-sulfonyl)-biphenyl-4-yl¨-ethyl}-2-methyl-pyrrolidine
02/16/2011EP1379498B1 Sulphones which modulate the action of gamma secretase
02/16/2011CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands
02/16/2011CN101973923A Naphthalene ring and ester bond structure-containing bismaleimide type compound and preparation method thereof
02/16/2011CN101973922A Atorvastatin semi-strontium salt polymorphs as well as preparation and application thereof as HMG-CoA enzyme inhibitor
02/16/2011CN101973921A Method for removing methylamine and moisture in N-methyl pyrrolidone
02/15/2011US7888386 3-(phenoxyphenylmethyl)pyrrolidine compounds
02/15/2011US7888355 Compositions and methods for inhibiting growth and metastasis of melanoma
02/15/2011US7888285 2,4,6-phenyl substituted cyclic ketoenols
02/15/2011CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/10/2011US20110034706 Process for preparing n-vinylpyrrolidone from lactone-free pyrrolidone
02/10/2011US20110034461 Sf5 derivatives as par1 inhibitors, production thereof, and use as medicaments
02/09/2011EP2282200A2 Acousto-mechanical detection methods
02/09/2011EP2280940A1 Novel n-(2-amino-phenyl)-acrylamides
02/09/2011EP2280915A1 Novel ýf-18¨-labelled l-glutamic acid and l-glutamine derivatives (ii), use thereof and method for their production
02/09/2011EP1654224B1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
02/09/2011CN1910146B Aspartates useful as components in coating compositions and their preparation
02/09/2011CN101970404A Novel method for the production of sulphonylpyrroles as hdac inhibitors
02/09/2011CN101970403A Pesticidal condensed - ring aryl compounds
02/09/2011CN101970402A Pyrrolidine derivatives
02/09/2011CN101967117A Substituted pyrrole derivatives and their use as HMG-CO inhibitors
02/09/2011CN101328136B Aminoacid acidamide compounds and preparation thereof
02/08/2011US7884174 Imide-linked maleimide and polymaleimide compounds
02/08/2011CA2622694C Substituted cycloalkene derivative
02/08/2011CA2446924C 2-iminopyrrolidine derivatives
02/08/2011CA2369588C Anticancer calcium channel blockers
02/03/2011WO2011012810A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
02/03/2011WO2011012660A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process
02/03/2011WO2011012322A2 Synthesis and use of vildagliptin for the preparation of pharmaceutical dosage forms
02/03/2011WO2010117619A3 Amine-terminated telechelic polymers and precursors thereto and methods for their preparation
02/03/2011US20110028736 Zofenopril Calcium
02/03/2011US20110028681 In situ formation of hydroxy chain end functional polyolefins
02/03/2011US20110028476 Proton pump inhibitors
02/03/2011US20110028468 Compounds having npy y5 receptor antagonistic activity
02/03/2011US20110028463 Amide compounds
02/03/2011US20110028367 Photo-labile pro-fragrance conjugates
02/03/2011US20110027359 Novel Pharmaceutical Compositions Comprising Levetiracetam
02/03/2011CA2769349A1 Antitumor 1,2-diphenylpyrrole compounds and their preparation process
02/03/2011CA2767285A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
02/02/2011EP2280274A2 Acousto-mechanical detection system
02/02/2011EP2280001A1 Long-chain fatty acid elongation enzyme inhibitor comprising arylsulfonyl derivative as active ingredient
02/02/2011EP2280000A1 Compound having npy y5 receptor antagonist activity
02/02/2011EP1373237B1 Methods for producing oxirane carboxylic acids and derivatives thereof
02/02/2011EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition
02/02/2011CN1972904B Preparation of pregabalin and related compounds
02/02/2011CN101965332A 2-cyanobenzensulfonamide derivatives having pesticidal properties
02/02/2011CN101962354A Method for producing L-pyroglutamic acid bivalent alkaline earth metal salt
02/02/2011CN101962353A Preparation method of (R) or (S)-2-aminomethyl tetrahydropyrrole
02/02/2011CN101434570B Pyrrolidine derivative, and preparation and use thereof
02/02/2011CN101415673B Process for the preparation of an N-alkyl lactam with improved colour quality
02/01/2011US7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
02/01/2011US7879903 Optically active 3-aminopyrrolidine salt, process for production thereof, and method for optical resolution of 3-aminopyrrolidine
02/01/2011US7879902 Pyrrole derivatives, intermediates therefor, preparation and therapeutic use thereof
02/01/2011US7879886 such as N-benzyl-N-hydroxy-2-(3-hydoxypyridin-2-ene)-1,3-thiazolidine-4-carboxamide, used for reducing the population of Plasmodium in a human infested with Plasmodium protozoans and suffering from malaria
02/01/2011US7879863 Aniline derivatives
02/01/2011US7879854 2-morpholin-4-ylethyl 5-[3-[(2S)-1-[4-(1-hydroxyhexyl)phenyl]-5-oxopyrrolidin-2-yl]propyl]thiophene-2-carboxylate, useful in treating vision defects, inflammatory bowel disease and alopecia
02/01/2011US7879852 Melanocortin receptor agonists
1 ... 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 ... 404